<PAGE> 1
<TABLE>
<S> <C>
UNITED STATES -----------------------------
OMB Approval
SECURITIES AND EXCHANGE COMMISSION -----------------------------
WASHINGTON, D.C. 20549 OMB Number: 3235-0145
Expires: October 31, 1997
Estimated average burden
hours per response... 14.90
-----------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Palatin Technologies, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, Par Value $.01 Per Share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
696077304
- --------------------------------------------------------------------------------
(CUSIP Number)
</TABLE>
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4
<PAGE> 2
<TABLE>
<CAPTION>
================================================================================================
CUSIP NO 696077304 13G Page 2 of 4 Pages
================================================================================================
<S> <C> <C>
================================================================================================
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
TheraTech, Inc.
================================================================================================
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)___
Not applicable (b)___
================================================================================================
3 SEC USE ONLY
================================================================================================
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
================================================================================================
5 SOLE VOTING POWER
NUMBER OF
SHARES 363,636
BENEFICIALLY ==================================================
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING None
PERSON ==================================================
WITH 7 SOLE DISPOSITIVE POWER
363,636
==================================================
8 SHARED DISPOSITIVE POWER
None
================================================================================================
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
363,636
================================================================================================
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
Not applicable
================================================================================================
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.11%
================================================================================================
12 TYPE OF REPORTING PERSON*
CO
================================================================================================
</TABLE>
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 4
<PAGE> 3
SCHEDULE 13G
ITEM 1. ISSUER
(a) NAME OF ISSUER: Palatin Technologies, Inc.
(b) ADDRESS OF ISSUER'S 214 Carnegie Center
PRINCIPLE EXECUTIVE OFFICES: Suite 100
Princeton, New Jersey 08540
ITEM 2. REPORTING PERSON INFORMATION
(a) NAME OF PERSON FILING: TheraTech, Inc., a Delaware corporation
(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE:
TheraTech, Inc.
417 Wakara Way
Salt Lake City, Utah 84108
(c) CITIZENSHIP:
Delaware
(d) TITLE OF CLASS OF SECURITIES:
Common Stock
(e) CUSIP NUMBER:
696077304
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE PERSON FILING IS A
Not applicable
ITEM 4. OWNERSHIP
(a) AMOUNT BENEFICIALLY OWNED:
363,636
(b) PERCENT OF CLASS:
8.11%
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) SOLE POWER TO VOTE OR TO DIRECT THE VOTE:
363,636
(ii) SHARED POWER TO VOTE OR TO DIRECT THE VOTE:
0
Page 3 of 4
<PAGE> 4
SCHEDULE 13G
(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION
OF:
363,636
(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE
DISPOSITION OF:
0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY
Not applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
SIGNATURE
After reasonably inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: July 14, 1998
TheraTech, Inc.
s/Dinesh C. Patel
----------------------------
Dinesh C. Patel, Ph.D.
Chairman, President
and Chief Executive Officer
Page 4 of 4
